At the time of writing, Ideaya Biosciences Inc [IDYA] stock is trading at $25.93, up 0.04%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The IDYA shares have gain 4.89% over the last week, with a monthly amount glided 3.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ideaya Biosciences Inc [NASDAQ: IDYA] stock has seen the most recent analyst activity on September 18, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $50. Previously, Citizens JMP started tracking the stock with Mkt Outperform rating on September 04, 2025, and set its price target to $41. On September 04, 2025, Barclays initiated with a Overweight rating and assigned a price target of $40 on the stock. TD Cowen started tracking the stock assigning a Buy rating. Wells Fargo started tracking with a Overweight rating for this stock on June 26, 2025, and assigned it a price target of $44. In a note dated November 18, 2024, Stephens initiated an Overweight rating and provided a target price of $51 on this stock.
For the past year, the stock price of Ideaya Biosciences Inc fluctuated between $13.45 and $36.64. Currently, Wall Street analysts expect the stock to reach $41 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $25.93 at the most recent close of the market. An investor can expect a potential return of 58.12% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -54.89%, Pretax Profit Margin comes in at -47.29%, and Net Profit Margin reading is -47.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.31 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.61 points at the first support level, and at 25.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.14, and for the 2nd resistance point, it is at 26.35.
Ratios To Look Out For
It is important to note that Ideaya Biosciences Inc [NASDAQ:IDYA] has a current ratio of 12.39. Also, the Quick Ratio is 12.39, while the Cash Ratio stands at 2.07. Considering the valuation of this stock, the price to sales ratio is 324.66, the price to book ratio is 2.37.
